HCPCS C-Codes
Temporary Codes for Use with Outpatient Prospective Payment System

  • C9070

    Injection, tafasitamab-cxix, 2 mg

  • C9071

    Injection, viltolarsen, 10 mg

  • C9072

    Injection, immune globulin (asceniv), 500 mg

  • C9073

    Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • C9074

    Injection, lumasiran, 0.5 mg

  • C9075

    Injection, casimersen, 10 mg

  • C9076

    Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • C9077

    Injection, cabotegravir and rilpivirine, 2mg/3mg

  • C9078

    Injection, trilaciclib, 1 mg

  • C9079

    Injection, evinacumab-dgnb, 5 mg
  • Continued

  • C9080

    Injection, melphalan flufenamide hydrochloride, 1 mg

  • C9081

    Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • C9082

    Injection, dostarlimab-gxly, 100 mg

  • C9083

    Injection, amivantamab-vmjw, 10 mg

  • C9084

    Injection, loncastuximab tesirine-lpyl, 0.1 mg

  • C9085

    Injection, avalglucosidase alfa-ngpt, 4 mg

  • C9086

    Injection, anifrolumab-fnia, 1 mg

  • C9087

    Injection, cyclophosphamide, (auromedics), 10 mg

  • C9088

    Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg

  • C9089

    Bupivacaine, collagen-matrix implant, 1 mg

  • C9090

    Injection, plasminogen, human-tvmh, 1 mg

  • C9091

    Injection, sirolimus protein-bound particles, 1 mg

  • C9092

    Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg

  • C9093

    Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

  • C9094

    Inj, sutimlimab-jome, 10 mg

  • C9095

    Inj, tebentafusp-tebn, 1 mcg

  • C9096

    Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

  • C9097

    Inj, faricimab-svoa, 0.1 mg

  • C9098

    Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • C9101

    Injection, oliceridine, 0.1 mg
  • Continued

  • C9113

    Injection, pantoprazole sodium, per vial

  • C9121

    Injection, argatroban, per 5 mg

  • C9122

    Mometasone furoate sinus implant, 10 micrograms (sinuva)

  • C9132

    Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

  • C9133

    Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.

  • C9134

    Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.

  • C9135

    Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.

  • C9136

    Injection, factor viii, fc fusion protein, (recombinant), per i.u.

  • C9137

    Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.

  • C9138

    Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.

  • C9139

    Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.

  • C9140

    Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.

  • C9141

    Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

  • C9142

    Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

  • C9143

    Cocaine hydrochloride nasal solution (numbrino), 1 mg

  • C9144

    Injection, bupivacaine (posimir), 1 mg

  • C9145

    Injection, aprepitant, (aponvie), 1 mg   Discontinued

  • C9146

    Injection, mirvetuximab soravtansine-gynx, 1 mg

  • C9147

    Injection, tremelimumab-actl, 1 mg

  • C9148

    Injection, teclistamab-cqyv, 0.5 mg